Calliditas Therapeutics — Major Shareholding Notification 2018

Jul 31, 2018

Issuer Calliditas Therapeutics AB

Holder

195303 Bengt Julander

Instrument

Instrument	Ordinary Shares SE0010441584
Before the transaction
Shares	Data not given*
Voting rights	Data not given*
Transaction
Reason for major shareholding notification Corporate action
Date	31/07/2018
Limit for number of shares	15 %
Limit for number of votes	15 %
After the transaction
Quantity
Shares	4,626,272
Directly held voting rights	636,000
Indirectly held voting rights	3,990,272
Percentage
Directly held shares	13.14194 %
Directly held voting rights	1.8067 %
Indirectly held voting rights	11.33524 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	13.14194 %	4,626,272
Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3	1.84646 %	649,999
- Physically settled - Cash settled
Total	14.9884 %	5,276,271
Chain of controlling companies Voting rights % Voting rights Company
4,640,271 13.18171 Linc AB
Group total holdings Voting rights 5,276,271 Percentage of voting rights 14.98841
Notes (other relevant informations according to law)
Flaggningen avser utspädning till följd av emission av nya aktier i Calliditas.
Published 31/07/2018 13:16

Contact Name Bengt Julander Phone +46703195909 Email bengt.julander@inc.se

*Source of information has chosen not to submit the data

CLOSE PRINT

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25